SCHEMBL19320172

SCHEMBL19320172

c1ccc(-c2cccc(-n3c4ccccc4c4cc5c(cc43)sc3c4[nH]c6ccccc6c4c4ccccc4c53)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K9 P80192 3/20 0.36
▸ MAP3K11 Q16584 3/20 0.36
▸ CDK4 P11802 1/20 0.36
▸ CCND1 P24385 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ TNKS O95271 1/20 0.34
▸ TNKS2 Q9H2K2 1/20 0.34
▸ NTRK1 P04629 1/20 0.34
▸ MAP3K10 Q02779 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ PPARG P37231 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NCOA2 Q15596 1/20 0.33
▸ NCOA1 Q15788 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19320190 0.93 MEN1 (0.33) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL17548802 0.92 MAP3K9 (0.38) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL19320176 0.92 KDM4E (0.41) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL19325130 0.90 MEN1 (0.34) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL19320112 0.88 MEN1 (0.40) MEN1MAPTRAB9AKMT2ATNKS
SCHEMBL19320168 0.87 HTR2B (0.33) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL19325075 0.86 MEN1 (0.40) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL19325048 0.86 MEN1 (0.38) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL19320182 0.85 MEN1 (0.34) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL19320169 0.85 GABRP (0.35) CDK4CCND1KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10381574-B2 Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same DUK SAN NEOLUX CO., LTD. (KR) 2019-08-13 — — US disclosed
US-20190103561-A1 Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same DUK SAN NEOLUX CO., LTD (KR) 2019-04-04 — — US disclosed
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD (KR) 2017-09-07 — — US disclosed
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD (KR) 2017-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME ORAI2, VDAC2, PIEZO1 MAP3K9 2567/4885MAP3K11 3377/4885CDK4 1500/4885
US-20190103561-A1 Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same ORAI2, VDAC2, PIEZO1 MAP3K9 2567/4885MAP3K11 3377/4885CDK4 1500/4885
US-10381574-B2 Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same ORAI2, VDAC2, PIEZO1 MAP3K9 2567/4885MAP3K11 3377/4885CDK4 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback